Laser Assisted Nano Engineering group (LANE) at the University of Nebraska-Lincoln was established in fall of 2002 by professor Yongfeng Lu. LANE group carries out state of art research in the field of nanotechnology using lasers. We aim to develop novel techniques using lasers for various applications including surface cleaning, building photonic devices, nanoimprinting, nano-manufacturing, nano-Raman and Coherent Anti-Stokes Raman Scattering (CARS) microscopy.
The InterNano Directory of Experts and Organizations is a listing of both researchers and research organizations that are engaged in nanomanufacturing.
Genisphere is a targeted drug delivery platform company and provider of an innovative DNA-based nanotechnology called 3DNA. Genisphere seeks additional partnerships with biotechnology and pharmaceutical companies that could benefit from the company's platform technology, which is IP-protected and fully customizable to deliver small molecules, biologics, and nucleic acids in a highly targeted manner.
Talga Resources Ltd (ASX:TLG) is a technology materials company with a unique, simple and cost-effective process to liberate graphene and nanographite directly from our large, high-quality ore deposits in nothern Sweden. By solving the cost and volume issues that have previously stymied commercialisation. Talga intends to enable widespread adoption of nanographitic carbons into current markets worth over $700Bn.
NanoXplore is a Montreal-based company specializing in the unique science of graphene and its derivative materials, and is very well placed to address three key challenges facing the graphene industry today:
The A.J. Drexel Nanomaterials Institute (DNI) coordinates interdisciplinary research, education and outreach, and strategic partnerships in nanomaterials for all of Drexel University. Faculty, students, and industry partners collaborate in activities ranging from core research to improving the public’s understanding and interest in nanoscale materials.
The High-Performance Materials Institute (HPMI) is a multidisciplinary research institute at Florida State University. HPMI strives to recruit, develop and retain top quality faculty and staff who will develop HPMI into a center of excellence for research and education in the field of advanced materials. Leading edge, revolutionary technology comes as the result of creativity, vision, talent, dedication and teamwork.
N12 is a Cambridge, Massachusetts-based startup that’s commercializing revolutionary nanotechnology to enhance composite materials. Based on MIT-developed and exclusively licensed vertically aligned carbon nanotube (VACNT) technology, N12 has created the world’s first commercial-scale continuous manufacturing capability for its Nanostitch™ product. Nanostitch™ improves shear properties of carbon-fiber and other composite materials by 10-40% and lengthens fatigue life 100 fold.
A multidisciplinary and internationally leading center devoted to the design and development of advanced coatings based on two-dimensional (2D) layered materials.
To contribute to the nation’s research infrastructure base by developing long-term partnerships among industry, academia and government
To leverage NSF funds with industry to support graduate students performing industrially relevant research
The University of Washington – Washington Nanofabrication Facility (UW WNF) is a national user facility that is a part of the National Nanotechnology Infrastructure Network (NNIN). Located on the University of Washington, Seattle campus, UW WNF is a full service micro and nanotechnology user facility and is the largest public access fabrication center in the Pacific Northwest, with 15,000sf of laboratories, cleanrooms, and user spaces focused on enabling basic and applied research, advanced research and development, and prototype production.
As the only industry group in existence that focuses on the scientific and regulatory aspects and policy needs of nanomedicines, the Alliance has the following vision and mission:
To catalyze the use of nanomedicines for patient benefit.
To promote and facilitate the scientific advancement, regulatory approval, safe use and public appreciation of nanotechnology-based medicines world-wide for the diagnosis, treatment and prevention of disease.